G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation of resistant or relapsing acute leukemias

Leukemia

Volumn 10, Issue 5, 1996, Pages 860-865

  Rambaldi, A ^a   Viero, P ^a   Bassan, R ^a   Buelli, M ^a   Rossi, A ^a   Bellavita, P ^a   Spinelli, O ^a   Amaru, R ^a   Micheletti, M ^a   Borleri, G ^a   Cortelazzo, S ^a   Comotti, B ^a   Barbui, T ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Allogeneic transplantation; Peripheral blood stem cells

Indexed keywords

BUSULFAN; CD34 ANTIGEN; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LEUKEMIA; ADULT; ALLOGRAFT; ANIMAL CELL; ARTICLE; CELL SEPARATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; INTERSTITIAL PNEUMONIA; LEUKAPHERESIS; LEUKEMIA REMISSION; LUNG ASPERGILLOSIS; MALE; NAUSEA; NEUTROPHIL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; STOMATITIS; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE; TREATMENT OUTCOME; VOMITING; WHOLE BODY RADIATION;

EID: 9344269889     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. + hematopoietic stem cells in the peripheral blood of high dose cyclophosphamide treated patients: enhancement by intravenous recombinant human granulocytemacrophage colony stimulating factor. Blood 1989; 74: 1905-1914.
2. Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G. Granulocyte colony stimulating factor to harvest circulating haematopoietic stem cells for autotransplantation. Lancet 1989; 2: 580-585.
3. Cortelazzo S, Viero P, Bellavita P, Rossi A, Buelli M, Borleri GM, Marziali S, Bassan R, Comotti B, Rambaldi A, Barbui T. Granulocyte colony-stimulating factor following peripheral blood progenitor cell transplant in non-Hodgkin's lymphoma. J Clin Oncol 1995; 13: 935-941.
4. Barlogie B, Jagannath S, Vesole D, Tricot G. Autologous and allogeneic transplants for multiple myeloma. Semin Hematol 1995; 32: 31-44.
5. Elias AD, Ayash L, Anderson KC, Hunt M, Wheeler C, Schwartz G, Tepler I, Mazanet R, Lynch C, Pap S, Pelaez J, Reich E, Critchlow J, Demetri G, Bibbo J, Schnipper L, Griffin JD, Frei III E, Antman KH. Mobilisation of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992; 79: 3036-3044.
6. Molineux G, Pojda Z, Hampson IN, Lord BI, Dexter TM. Transplantation potential of peripheral blood stem cells induced by granulocites colony-stimulating factor. Blood 1990; 76: 2153-2158.
7. Baumann I, Testa NG, Lange C, Luft T, Dexter TM, de Wynter E, Luft T, Dexter TM, van Hoef MEHM, Howell A. Haemopoietic cells mobilised into the circulation by lenograstim as alternative to bone marrow for allogeneic transplants. Lancet 1993; 341: 369.
8. Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, Williams B, Storb R, Thomas ED, Buckner CD. The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883-1888.
9. Weaver CH, Buckner CD, Longin K, Appelbaum FR, Rowley S, Lilleby K, Miser J, Storb R, Hansen JA, Bensinger W. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993; 82: 1981-1984.
10. Mackinnon S, Barnett L, Bourhis JH, Black P, Heller G, O'Reilly RJ. Myeloid and lymphoid chimerism after T-cell depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Blood 1992; 80: 3235-3241.
11. Ugozzoli L, Yam P, Petz LD, Ferrara GB, Champlin RE, Forman SJ, Koyal D, Wallace RB. Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood 1991; 77: 1607-1615.
12. Lawler M, Humphries P, McCann SR. Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction, Blood 1991; 77: 2504-2514.
13. Boerwinkle E, Xiong W, Fourest E, Chan L. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci USA 1989; 86: 212-219.
14. Tanaka J, Kasai M, Imamura M, Masauzi N, Ohizumi H, Matsuura A, Morii K, Kiyama Y, Naohara T, Saitoh M, Higa T, Sakurada K, Miyazaki T. Evaluation of mixed chimaerism and origin of bone marrow derived fibroblastoid cells after allogeneic bone marrow transplantation. Br J Haematol 1994; 86: 436-438.
15. Rambaldi A, Bettoni S, Tosi S, Giudici G, Schirò R, Borleri GM, Abbate M, Chiaffarino F, Colotta F, Barbui T, Biondi A. Establishment and characterization of a new GM-CSF and IL-3 dependent human acute myeloid leukemia cell line (GF-D8). Blood 1993; 81: 1376-1383.
16. Bassan R, Battista R, Viero P, Pogliani E, Rossi G, Lambertenghi-Deliliers G, Rambaldi A, D'Emilio A, Buelli M, Borleri G, Corneo G, Dini E, Barbui T. Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/ i.-asparaginase/prednisolone regimen. Semin Oncol 1993; 20 (Suppl. 8): 39-46.
17. Bassan R, Battista R, Viero P, D'Emilio A, Buelli M, Montaldi A, Rambaldi A, Tremul L, Dini E, Barbui T. Short term treatment for adult hypergranular and microgranular acute promyelocytic leukemia. Leukemia 1995; 9: 238-243.
18. Rohatiner AZS, Battista R, Bassan R, Love R, Oza AM, Whelan JS, Lim J, Buelli M, Viero P, D'Emilio A, Barbui T, Lister TA. Short term therapy (STT) for acute myelogenous leukemia (AML). Leukemia 1992; 6 (Suppl. 2): 85-88.
19. Weyman C, Graham-Pole J, Emerson S, August C, Champlin R, Coccia P, Fay J, Harris R, Koch, Johnson, Pick T, Souillet C, Spruce W, Vega R, Vogler WR, Willoughby M, Woods W. Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey. Bone Marrow Transplant 1993; 11: 43-50.
20. Helenglass G, Powles RL, McElwain TJ, Lakhani A, Milan S, Gore M, Nandi A, Zuiable A, Perren T, Forgeson G, Treleavan J, Hamilton C, Millar J. Melphalan and total body irradiation (FTBI) versus cyclophosphamide and FTBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukemia in first remission. Bone Marrow Transplant 1988; 3: 21-29.
21. Storb R, Deeg HJ, Whithead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum R, Martin, P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
22. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-2101.
23. Barbui T, Grassi A, Marchioli R, Finazzi G. Thrombosis in cancer patients treated with hematological growth factors. Thromb Haemost 1995; 73: 1285 (Abstr. 1479).
24. Socinski MA, Cannistra SA, Sullivan R, Elias A, Antman K, Schnipper L, Griffin JD. Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11 b surface adhesion molecule on human granulocytes in vivo. Blood 1988; 72: 691-696.
25. Turner ML, Mcllwaine K, Anthony RS, Parker AC. Differential expression of cell adhesion molecules by human haematopoietic progenitor cells from bone marrow and mobilized adult peripheral blood. Stem Cells 1995; 13: 311-316.
26. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealife M, Terstappen LWMM, Hardwick A, Moubayed M, Oldham F, Corringham RET, Ho AD. Harvesting and enrichment of hematopoietic progenitor cells mobilized into peripheral blood of normal donors by granulocyte-macrophage colony stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275-282.
27. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
28. Schmitz N, Dreger P, Suttorp N, Rohwedder B, Haferlach T, Loffler H, Hunter A, Russell NH. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
29. Korbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
30. Russell JA, Luider J, Weaver M, Brown C, Selinger S, Railton C, Karlsson L, Klassen J. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995; 15: 111-115.
31. Martinez JA, Picon I, Carrai A, de la Rubia J, Sanz GF, Sanz MA. Allogeneic peripheral blood progenitor cells mobilized by G-CSF (filgrastim) for a second transplant in a patient with acute myeloid leukemia in relapse: Bone Marrow Transplant 1995; 15: 149-151.
32. Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C, lacucci R, Zei T, Martelli MP, Gambelunghe C, Rossetti M, Caputo P, Latini P, Aristei C, Raymondi C, Reisner Y, Martelli MF. Successful engraftment of T-cell-depleted haploidentical 'three-Loci' incompatible transplants in leukemia patients by addition of recombinanl human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
33. Berman E, Little C, Gee T, O'Reilly R, Clarkson B. Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation. New Engl J Med 1992; 326: 156-160.
34. Radich JP, Sanders JE, Buckner CD, Martin PJ, Petersen FB, Besinger W, McDonald GB, Mori M, Schoch G, Hansen JA. Second allogeneic marrow transplantation tor patients with recurrent leukemia after initial transplant with total body irradiation containing regimens. J Clin Oncol 1993; 11: 304-313.
35. Mrsic M, Horowitz MM, Atkinson K, Biggs JC, Champlin RE, Ehninger G, Cajewski JL, Cale RP, Herzig RH, Prentice HC, Rozman C, Sobocinski KA, Speck B, Bortin MM. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 1992; 9: 269-275.
36. Kumar L. Leukemia: management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 1994; 12: 1710-1717.
37. Vogelsang CB, Hess AD. Craft-versus-host disease: new directions for a persistent problem. Blood 1994; 84: 2061-2067.
38. Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro-Malaspina H, Childs BH, Gillio AP, Kernan NA, Small TN, Young JW, O'Reilly R. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261-1268.